![John M. Padfield](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John M. Padfield
Chairman at Cambridge Laboratories Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Handel E. Evans | M | - |
Cambridge Laboratories Ltd.
![]() Cambridge Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Cambridge Laboratories is a fast growing, dynamic and entrepreneurial pharmaceutical company with extensive product development and commercialization expertise. Their focus is on specialist pharmaceuticals with core products in Oncology and diseases of the central nervous system (CNS). They have a proven track record in the development, global registration, marketing, sales and distribution of both innovative and well established pharmaceutical products. This combined with its strong product portfolio and their ability to forge lasting relationships with global partners, has helped them generate substantial sales growth over the past 13 years. They are proud of its independence and entrepreneurial culture. Equally, their strong balance sheet and freedom from debt give them a solid foundation from which they continue to enhance its growth. Cambridge Laboratories is an independent and privately owned company, founded in 1987 and purchased outright by members of the current Board of Directors in 1996. | - |
Bernard Taylor | M | - |
Cambridge Laboratories Ltd.
![]() Cambridge Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Cambridge Laboratories is a fast growing, dynamic and entrepreneurial pharmaceutical company with extensive product development and commercialization expertise. Their focus is on specialist pharmaceuticals with core products in Oncology and diseases of the central nervous system (CNS). They have a proven track record in the development, global registration, marketing, sales and distribution of both innovative and well established pharmaceutical products. This combined with its strong product portfolio and their ability to forge lasting relationships with global partners, has helped them generate substantial sales growth over the past 13 years. They are proud of its independence and entrepreneurial culture. Equally, their strong balance sheet and freedom from debt give them a solid foundation from which they continue to enhance its growth. Cambridge Laboratories is an independent and privately owned company, founded in 1987 and purchased outright by members of the current Board of Directors in 1996. | - |
Mark Evans | M | - |
Cambridge Laboratories Ltd.
![]() Cambridge Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Cambridge Laboratories is a fast growing, dynamic and entrepreneurial pharmaceutical company with extensive product development and commercialization expertise. Their focus is on specialist pharmaceuticals with core products in Oncology and diseases of the central nervous system (CNS). They have a proven track record in the development, global registration, marketing, sales and distribution of both innovative and well established pharmaceutical products. This combined with its strong product portfolio and their ability to forge lasting relationships with global partners, has helped them generate substantial sales growth over the past 13 years. They are proud of its independence and entrepreneurial culture. Equally, their strong balance sheet and freedom from debt give them a solid foundation from which they continue to enhance its growth. Cambridge Laboratories is an independent and privately owned company, founded in 1987 and purchased outright by members of the current Board of Directors in 1996. | - |
David Wildy | M | - |
Cambridge Laboratories Ltd.
![]() Cambridge Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Cambridge Laboratories is a fast growing, dynamic and entrepreneurial pharmaceutical company with extensive product development and commercialization expertise. Their focus is on specialist pharmaceuticals with core products in Oncology and diseases of the central nervous system (CNS). They have a proven track record in the development, global registration, marketing, sales and distribution of both innovative and well established pharmaceutical products. This combined with its strong product portfolio and their ability to forge lasting relationships with global partners, has helped them generate substantial sales growth over the past 13 years. They are proud of its independence and entrepreneurial culture. Equally, their strong balance sheet and freedom from debt give them a solid foundation from which they continue to enhance its growth. Cambridge Laboratories is an independent and privately owned company, founded in 1987 and purchased outright by members of the current Board of Directors in 1996. | - |
Boyd Diana | M | - |
Cambridge Laboratories Ltd.
![]() Cambridge Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Cambridge Laboratories is a fast growing, dynamic and entrepreneurial pharmaceutical company with extensive product development and commercialization expertise. Their focus is on specialist pharmaceuticals with core products in Oncology and diseases of the central nervous system (CNS). They have a proven track record in the development, global registration, marketing, sales and distribution of both innovative and well established pharmaceutical products. This combined with its strong product portfolio and their ability to forge lasting relationships with global partners, has helped them generate substantial sales growth over the past 13 years. They are proud of its independence and entrepreneurial culture. Equally, their strong balance sheet and freedom from debt give them a solid foundation from which they continue to enhance its growth. Cambridge Laboratories is an independent and privately owned company, founded in 1987 and purchased outright by members of the current Board of Directors in 1996. | - |
Anne Marie Cairns | F | - | 17 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Rosalyn Wilton | F | 72 | - | |
Gordon Davis | M | 67 | 8 years | |
Christine Soden | F | 66 | 3 years | |
Alexander Warnock | M | 59 | - | |
Barry Michael Rose | M | 79 | - | |
Thomas W. Butts | M | 63 | 2 years | |
Michael Geraghty | M | 76 | - | |
Richard Coose | M | - | - | |
Barry Edward Sealey | M | - | - | |
Thomas Motta | M | - | - | |
David John Cairns | M | 59 | - | |
Ian Herbert Stevens | M | 61 | 9 years | |
Saad Hassan Hammad | M | 62 | 2 years | |
Allan Mark Watson | M | 57 | 6 years | |
Stéphane Sallmard | M | - | 5 years | |
David Guyer | M | 64 | 3 years | |
Jim Milkay | M | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
United Kingdom | 23 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John M. Padfield
- Personal Network